Fig. 3.
Fig. 3. Examples of mechanisms that cells can use for the in vivo for the control of effective ligand concentrations and receptor expression (and thus the level of receptor-ligand complex activation). / (1) Preventing or diminishing ligand/receptor complex internalization through interactions between extracellular matrix (shown) or cell-surface bound ligands; (2) autocrine ligand secretion; (3) interactions with proteins secreted by other cells (either locally or systemically); (4) ligand interactions with agonistic or antagonistic soluble receptors (shown) or nonreceptor cytokine binding proteins (eg, uromodulin); (5) receptor internalization/synthesis; and (6) proteolytic cleavage of surface-bound receptors (shown) and/or ligands. Each of these mechanisms may determine whether a particular (threshold) level of receptor ligand activation is achieved. See text for further discussion.

Examples of mechanisms that cells can use for the in vivo for the control of effective ligand concentrations and receptor expression (and thus the level of receptor-ligand complex activation).

(1) Preventing or diminishing ligand/receptor complex internalization through interactions between extracellular matrix (shown) or cell-surface bound ligands; (2) autocrine ligand secretion; (3) interactions with proteins secreted by other cells (either locally or systemically); (4) ligand interactions with agonistic or antagonistic soluble receptors (shown) or nonreceptor cytokine binding proteins (eg, uromodulin); (5) receptor internalization/synthesis; and (6) proteolytic cleavage of surface-bound receptors (shown) and/or ligands. Each of these mechanisms may determine whether a particular (threshold) level of receptor ligand activation is achieved. See text for further discussion.

Close Modal

or Create an Account

Close Modal
Close Modal